Medically reviewed by Dr. Pamela Frank, BSc(Hons), ND – Updated July 2026
What Is Implantation Failure?
Implantation is the most vulnerable step in human reproduction. A viable embryo can fail to implant – or implant and fail to progress – for reasons entirely independent of fertilization. When this happens repeatedly, it is classified as recurrent implantation failure (RIF).
There is no universally agreed-upon definition of RIF, but the most commonly used clinical threshold is failure to achieve a clinical pregnancy after transfer of at least three good-quality embryos in at least two IVF cycles, or after two transfers of blastocyst-stage embryos.1 Outside of IVF, implantation failure in natural cycles presents as the inability to conceive despite confirmed ovulation, normal semen parameters, and patent fallopian tubes, which often becomes labelled as unexplained infertility.
Implantation failure is not a single diagnosis. It is a clinical outcome with multiple possible causes, each requiring different investigation and treatment. The most important thing a clinician can do when faced with repeated implantation failure is to determine which of those causes is operative, rather than applying a generic protocol.
The Biology of Implantation
Successful implantation requires that three factors coincide precisely: a chromosomally normal embryo, a receptive endometrium, and a synchronized immune environment at the maternal-fetal interface.
The receptive window (called the window of implantation (WOI)) opens approximately 6–10 days after ovulation, during the mid-secretory phase of the cycle. During this window, the endometrium expresses specific surface molecules (integrins, pinopodes, LIF, and others) that allow the blastocyst to adhere and begin invasion. Disruption of any component of this timed process – the embryo, the endometrium, or the immune environment – can prevent implantation even when everything else appears normal on standard testing.
Causes of Implantation Failure
Embryo Factors
Chromosomal aneuploidy
Chromosomal aneuploidy is the single most common cause of implantation failure and early pregnancy loss. The majority of human embryos, particularly in women over 35, carry chromosomal abnormalities that prevent normal development beyond the implantation stage.2 In the context of IVF, preimplantation genetic testing for aneuploidy (PGT-A) can identify euploid embryos for transfer, which significantly improves implantation rates per transfer. This is a conversation for your reproductive endocrinologist.
Sperm DNA fragmentation
DNA fragmentation contributes to implantation failure and early embryo arrest independently of standard semen analysis results. A man can have a completely normal sperm count, motility, and morphology and still have DNA fragmentation rates sufficient to prevent normal embryo development after fertilization.3 This is covered in more detail on the unexplained infertility page →.
Uterine and Endometrial Factors
Thin uterine lining:
Endometrial thickness below 7-8 mm at the time of transfer is associated with significantly reduced implantation rates. The mechanisms (impaired uterine blood flow, estrogen deficiency, Asherman’s syndrome, chronic endometritis, hormone imbalance) are each treatable when correctly identified. Full coverage on the thin uterine lining page →.
Structural uterine abnormalities:
Submucosal fibroids, endometrial polyps, uterine septum, and intrauterine adhesions can physically impede implantation or distort the uterine cavity in ways that create a hostile environment for the embryo. These are diagnosed by saline infusion sonohysterography (SIS), hysteroscopy, or 3D ultrasound and require surgical correction before implantation can succeed. No naturopathic intervention substitutes for this step.
Displaced window of implantation:
The ERA (Endometrial Receptivity Analysis) test evaluates gene expression patterns in endometrial biopsy tissue to determine whether a woman’s window of implantation is synchronized with a standard embryo transfer protocol. Approximately 25–30% of women with RIF have a displaced WOI; their receptive window opens earlier or later than the protocol assumes.4 This is a medical investigation offered by some reproductive clinics and is relevant for women who have had multiple failed transfers with euploid embryos.
Chronic endometritis (CE):
Low-grade bacterial infection of the endometrial cavity causes persistent inflammation, plasma cell infiltration, and disruption of the immune environment required for implantation. CE is frequently asymptomatic. There are no signs like abnormal discharge, fever, or pain, and it is invisible on standard ultrasound.5 Diagnosis requires an endometrial biopsy with CD138 immunohistochemistry to identify plasma cells. Studies enrolling women with recurrent implantation failure have found CE present in a significant proportion of these patients. Treatment is targeted antibiotic therapy based on culture results. This is a medical intervention requiring referral and is not within the naturopathic prescribing scope in Ontario.
Immunological Factors
Uterine natural killer (uNK) cell dysregulation:
Natural killer cells in the uterus play a critical and paradoxical role. They are essential for normal implantation and placentation, but in elevated numbers or with altered activity, they can attack the implanting embryo. Peripheral blood NK cell testing and uterine NK cell biopsy are offered by some reproductive immunology clinics. The evidence base for treatment interventions (intralipid infusion, IVIG, prednisolone) remains evolving and contested; referral to a reproductive immunologist is appropriate for women with confirmed elevated NK activity and multiple implantation failures.6
Antiphospholipid syndrome (APS) and thrombophilia:
Antiphospholipid antibodies (including anticardiolipin antibodies, anti-β2-glycoprotein I antibodies, and lupus anticoagulant) cause microvascular thrombosis in the developing placental vasculature, interfering with trophoblast invasion and early placentation. APS is among the most clearly treatable causes of both recurrent implantation failure and recurrent miscarriage; low-molecular-weight heparin combined with low-dose aspirin is the standard treatment and substantially improves outcomes in confirmed APS.7 This requires medical testing and management.
Inherited thrombophilias, Factor V Leiden, prothrombin gene mutation G20210A, protein C and S deficiency, have a less definitive evidence base for treatment in RIF than APS, but warrant testing in women with RIF alongside other workup.
Alloimmune factors:
Incompatibility between maternal and paternal HLA (human leukocyte antigen) profiles and failure of normal maternal immune tolerance to paternal antigens have been proposed as mechanisms underlying unexplained RIF. The evidence base is preliminary, and the clinical interventions (lymphocyte immunization therapy, IVIG) are investigational; this remains an area of active research rather than established clinical practice.
Endocrine Factors
Thyroid dysfunction and autoimmunity:
Hypothyroidism and thyroid autoimmunity independently impair endometrial receptivity. Anti-TPO antibodies are associated with implantation failure and miscarriage, even in euthyroid women; the mechanism involves immune dysregulation at the maternal-fetal interface rather than thyroid hormone insufficiency alone.8 TSH target for women attempting conception or undergoing IVF is below 2.5 mIU/L; the standard laboratory reference range is not appropriate in this context.
Luteal phase insufficiency:
Inadequate progesterone production after ovulation fails to complete the endometrial transformation required for implantation. Luteal phase defect can result from poor follicular development, premature LH surges, hyperprolactinemia, hyperandrogenemia, or suboptimal corpus luteum function. A 7-day post-ovulation progesterone level below 30 nmol/L suggests inadequate luteal function in a natural cycle.
Insulin resistance and metabolic dysfunction:
Women with PCOS and insulin resistance have altered endometrial immune cell profiles – including dysregulated NK cells and macrophages – that create a state of chronic low-grade endometrial inflammation independent of obesity.9 Elevated insulin also impairs endometrial glucose uptake and disrupts the molecular markers of the window of implantation. Insulin resistance is present in lean women with or without PCOS and is frequently missed when only fasting glucose is measured.
Elevated prolactin:
Mildly elevated prolactin – below the threshold most labs flag as abnormal – suppresses LH pulsatility, shortens the luteal phase, and impairs the progesterone-driven secretory transformation of the endometrium. Subclinical hyperprolactinemia is one of the more consistently underdiagnosed drivers of implantation failure in a standard workup.
The Endometrial Microbiome
Emerging research has identified the endometrial microbiome as a clinically relevant factor in implantation. Dominance of Lactobacillus species in the female reproductive tract is associated with eubiosis and improved implantation outcomes, while endometrial dysbiosis – characterized by reduced Lactobacillus and higher proportions of pathogenic genera including Gardnerella, Prevotella, Atopobium, and Streptococcus – is associated with impaired endometrial receptivity and increased implantation failure rates through local inflammation and elevated pro-inflammatory cytokines.
This field is still developing – there is not yet a standardized clinical test or treatment protocol for endometrial dysbiosis outside of research settings – but it represents a plausible mechanism in women with RIF of otherwise unclear cause, particularly those with a history of recurrent vaginal infections or antibiotic use.
What I Investigate That Standard Workup Misses
A standard pre-IVF workup covers uterine structure (ultrasound or hysteroscopy), basic hormones, and semen analysis. What is frequently absent:
Full thyroid panel including antibodies:
TSH alone misses autoimmune thyroid disease. Anti-TPO and anti-thyroglobulin antibodies should be measured in every woman with RIF; positive antibody results alter the immune picture regardless of whether TSH is normal.
Fasting insulin and HOMA-IR:
Not ordered in standard fertility workups despite the direct mechanistic link between insulin resistance and endometrial immune dysregulation. Essential in women with PCOS and in overweight or lean women with unexplained RIF.
7-day post-ovulation progesterone in natural cycles:
Frequently omitted when conception hasn’t occurred in natural cycles. Progesterone below 30 nmol/L seven days post-ovulation identifies luteal phase insufficiency that is directly addressable. Even better is to pair this test with Basal Body Temperature charting.
Antiphospholipid antibody panel:
Anticardiolipin IgG/IgM, anti-β2 glycoprotein I IgG/IgM, and lupus anticoagulant. These are not routine but should be standard in women with two or more implantation failures. Untreated APS is one of the few clearly correctable causes of RIF. Naturopathic doctors in Ontario cannot order this test.
Prolactin:
Measured at baseline (not under stress – prolactin is exquisitely sensitive to venipuncture stress and should be measured after 20 minutes of seated rest). Mildly elevated prolactin in the 20–40 mcg/L range, though technically within some lab reference ranges, is sufficient to disrupt luteal function.
Sperm DNA fragmentation index:
Not offered through most Ontario fertility clinics as a routine test. Available through specialized andrology labs. Indicated in couples with RIF where female factors have been investigated without a clear explanation.
Vitamin D (25-OH):
Vitamin D receptors are expressed on endometrial cells and uterine NK cells. Deficiency is independently associated with reduced implantation rates and impaired immune tolerance at the maternal-fetal interface.10 Vitamin D deficiency is common in Ontario. Measurements allow me to tailor the dose and also confirm that with adequate supplementation, your blood level has reached the optimal range.
Homocysteine and methylation markers:
Elevated homocysteine reflects impaired methylation and is associated with both implantation failure and recurrent pregnancy loss through effects on trophoblast function and vascular development. Identifies women who need 5-MTHF rather than folic acid regardless of MTHFR genotype.
Naturopathic Support for Implantation Failure
Naturopathic treatment addresses the modifiable contributors identified through workup. The following represents the evidence-informed foundation of this work:
Optimizing thyroid function and reducing thyroid autoimmunity
Selenium supplementation (200 mcg/day as selenomethionine) has reduced anti-TPO antibody titers in randomized controlled trials and is the most evidence-supported nutritional intervention for autoimmune thyroid disease.11 Reducing thyroid antibody burden has downstream benefits for endometrial immune regulation. Ensuring TSH is below 2.5 mIU/L requires collaboration with the prescribing physician where thyroid hormone is indicated.
Correcting insulin resistance
Dietary modification – low glycemic index/load, high fibre, adequate protein, reduced carbohydrates – is the most effective non-pharmacological intervention for insulin resistance. Inositol (myo-inositol 2g + D-chiro-inositol 50mg twice daily) has demonstrated improvements in insulin sensitivity, endometrial quality markers, and IVF outcomes in women with PCOS in multiple RCTs.12 This is particularly relevant for women with PCOS-associated RIF but extends to insulin-resistant women without a formal PCOS diagnosis.
Antioxidant support for embryo and endometrial quality
Oxidative stress impairs both oocyte and endometrial function. CoQ10 (ubiquinol 200–600 mg/day) supports mitochondrial function in oocytes and granulosa cells; melatonin (1–3 mg at bedtime) protects the developing follicle from reactive oxygen species; NAC (600 mg/day) supports glutathione synthesis and endometrial receptivity. These are discussed in detail on the egg quality page →.
Vitamin D optimization
Target 25-OH vitamin D of 100–150 nmol/L. This requires measured baseline levels and individualized dosing – typical maintenance in Ontario is 2,000–4,000 IU/day, but correction of deficiency may require higher doses short-term under monitoring.
Methylation support
Women with elevated homocysteine or confirmed MTHFR polymorphisms (C677T, A1298C) require methylated B vitamins: 5-methyltetrahydrofolate (5-MTHF) rather than folic acid, methylcobalamin rather than cyanocobalamin B12, and pyridoxal-5-phosphate rather than pyridoxine B6. A homocysteine level above 10 μmol/L warrants treatment regardless of MTHFR status.
Low-dose aspirin
Low-dose aspirin (81 mg/day) reduces thromboxane A2-mediated uterine vasoconstriction, improves endometrial blood flow, and is a standard adjunct in the medical management of APS- where it is used alongside heparin. Outside of confirmed APS, aspirin is used adjunctively to support uterine perfusion and should be discussed with the prescribing physician, particularly in the context of an IVF cycle.
Anti-inflammatory dietary pattern
Chronic systemic inflammation disrupts the tightly regulated immune environment required for implantation. A Mediterranean-patterned diet, adequate omega-3 fatty acid intake (at least 2g EPA/DHA daily from pharmaceutical-grade fish oil), and elimination of high-glycemic index/load and ultra-processed foods reduce the systemic inflammatory burden that undermines endometrial receptivity.
Addressing luteal phase insufficiency
Vitex agnus-castus (chaste tree berry) has the strongest naturopathic evidence base for supporting luteal phase adequacy. It acts on dopaminergic receptors in the pituitary to reduce prolactin and supports LH-driven progesterone production.13 It is not necessary in women already using progesterone supplementation in an IVF protocol; timing and context determine its appropriateness.
Acupuncture
Acupuncture around the time of embryo transfer is one of the more studied adjunct interventions in IVF. Proposed mechanisms include improved uterine blood flow, reduced sympathetic nervous system activation during the peri-transfer period, and modulation of pro-inflammatory cytokines. A 2019 systematic review and meta-analysis found that acupuncture performed around embryo transfer was associated with improved clinical pregnancy rates compared to sham acupuncture.14
What Requires Medical Referral for Implantation Failure
Naturopathic care addresses modifiable contributors. Several causes of RIF require medical intervention that is outside the naturopathic scope:
- Confirmed APS requires low-molecular-weight heparin and aspirin, managed by a physician or hematologist
- Chronic endometritis requires targeted antibiotic therapy; however, in addition, a fertility naturopath can help support healthy immunity, microbiome, and optimal hormone balance for a healthier uterine lining
- Structural abnormalities (fibroids, polyps, septum, adhesions) may require surgical correction
- Elevated uterine NK cells – where clinically confirmed – require reproductive immunology consultation
- A displaced window of implantation identified by ERA requires modified transfer timing within an IVF protocol
- Chromosomal aneuploidy in embryos requires PGT-A within an IVF cycle
In all of these situations, I work alongside, not instead of, the relevant medical specialist.
Frequently Asked Questions About Implantation Failure
What is the difference between implantation failure and miscarriage?
Implantation failure means the embryo never successfully implants – there is no detectable rise in hCG and no clinical pregnancy. Miscarriage means implantation occurred and a clinical pregnancy was established, but the pregnancy was subsequently lost. The distinction matters because the causes can be different: embryo chromosomal abnormalities are the dominant cause of both, but some causes, such as APS and uterine structural problems, disproportionately affect one more than the other.
Can implantation failure happen in natural cycles, not just IVF?
Yes. In natural cycles, implantation failure presents as the inability to conceive despite regular ovulation, normal semen parameters, and open fallopian tubes — which is the clinical picture of unexplained infertility. The same causes are operative; they are simply harder to investigate outside the context of an IVF cycle where embryo quality can be directly assessed.
How many failed IVF cycles before I should investigate further?
After two failed transfers with good-quality embryos, particularly blastocysts, additional investigation is warranted rather than simply repeating the same protocol. The investigations most likely to yield actionable findings are: an antiphospholipid antibody panel, thyroid antibody tests, fasting insulin, prolactin, an ERA test, and an endometrial biopsy for chronic endometritis.
Does stress cause implantation failure?
Elevated cortisol from chronic psychological stress suppresses GnRH pulsatility through CRH-mediated inhibition of the HPG axis and shifts immune activity in ways that may impair the immune tolerance required for implantation. The mechanistic link is plausible and supported by animal studies; the direct clinical evidence in humans is harder to isolate. Stress management is a legitimate component of fertility care, but it should sit alongside the investigation of structural, immunological, and endocrine causes rather than replace them.
Can naturopathic treatment improve implantation success?
Where modifiable contributors are identified – insulin resistance, thyroid autoimmunity, vitamin D deficiency, methylation impairment, luteal phase insufficiency, oxidative stress, poor uterine blood flow – addressing them creates a more optimal environment for implantation. Naturopathic treatment is not a substitute for medical investigation or treatment of APS, structural abnormalities, or chromosomal aneuploidy.
How long before a transfer should I start naturopathic treatment?
A minimum of three months is ideal to allow time to optimize nutritional status, correct deficiencies, address insulin resistance, and complete the full oocyte maturation cycle. Starting treatment earlier provides more runway, particularly for women with identified causes that take time to correct, such as vitamin D deficiency or elevated thyroid antibody levels.
Implantation Failure Research References
- Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, Cutting R, Ong K, Sallam H, Li TC. Recurrent implantation failure: definition and management. Reprod Biomed Online. 2014 Jan;28(1):14-38. doi: 10.1016/j.rbmo.2013.08.011. Epub 2013 Sep 14. PMID: 24269084.
- Munné S, Kaplan B, Frattarelli JL, Child T, Nakhuda G, Shamma FN, Silverberg K, Kalista T, Handyside AH, Katz-Jaffe M, Wells D, Gordon T, Stock-Myer S, Willman S; STAR Study Group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertil Steril. 2019 Dec;112(6):1071-1079.e7. doi: 10.1016/j.fertnstert.2019.07.1346. Epub 2019 Sep 21. PMID: 31551155.
- Tan J, Taskin O, Albert A, Bedaiwy MA. Association between sperm DNA fragmentation and idiopathic recurrent pregnancy loss: a systematic review and meta-analysis. Reprod Biomed Online. 2019 Jun;38(6):951-960. doi: 10.1016/j.rbmo.2018.12.029. Epub 2018 Dec 22. PMID: 30979611.
- Díaz-Gimeno P, Horcajadas JA, Martínez-Conejero JA, Esteban FJ, Alamá P, Pellicer A, Simón C. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril. 2011 Jan;95(1):50-60, 60.e1-15. doi: 10.1016/j.fertnstert.2010.04.063. Epub 2010 Jul 8. PMID: 20619403.
- Cicinelli E, Matteo M, Tinelli R, Pinto V, Marinaccio M, Indraccolo U, De Ziegler D, Resta L. Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. Reprod Sci. 2014 May;21(5):640-7. doi: 10.1177/1933719113508817. Epub 2013 Oct 31. PMID: 24177713; PMCID: PMC3984485.
- Moffett A, Colucci F. Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest. 2014 May;124(5):1872-9. doi: 10.1172/JCI68107. Epub 2014 May 1. PMID: 24789879; PMCID: PMC4001528.
- Coulam CB, Kaider BD, Kaider AS, Janowicz P, Roussev RG. Antiphospholipid antibodies associated with implantation failure after IVF/ET. J Assist Reprod Genet. 1997 Nov;14(10):603-8. doi: 10.1023/a:1022588903620. PMID: 9447463; PMCID: PMC3454732.
- Toth B, Jeschke U, Rogenhofer N, Scholz C, Würfel W, Thaler CJ, Makrigiannakis A. Recurrent miscarriage: current concepts in diagnosis and treatment. J Reprod Immunol. 2010 May;85(1):25-32. doi: 10.1016/j.jri.2009.12.006. Epub 2010 Feb 24. PMID: 20185181.
- Palomba S, Piltonen TT, Giudice LC. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2021 Apr 21;27(3):584-618. doi: 10.1093/humupd/dmaa051. PMID: 33302299.
- Skowrońska P, Pastuszek E, Kuczyński W, Jaszczoł M, Kuć P, Jakiel G, Wocławek-Potocka I, Łukaszuk K. The role of vitamin D in reproductive dysfunction in women – a systematic review. Ann Agric Environ Med. 2016 Dec 23;23(4):671-676. doi: 10.5604/12321966.1226865. PMID: 28030942.
- Ventura M, Melo M, Carrilho F. Selenium and Thyroid Disease: From Pathophysiology to Treatment. Int J Endocrinol. 2017;2017:1297658. doi: 10.1155/2017/1297658. Epub 2017 Jan 31. PMID: 28255299; PMCID: PMC5307254.
- Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017 Nov;6(8):647-658. doi: 10.1530/EC-17-0243. PMID: 29042448; PMCID: PMC5655679.
- van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med. 2013 May;79(7):562-75. doi: 10.1055/s-0032-1327831. Epub 2012 Nov 7. PMID: 23136064.
- Smith CA, Armour M, Shewamene Z, Tan HY, Norman RJ, Johnson NP. Acupuncture performed around the time of embryo transfer: a systematic review and meta-analysis. Reprod Biomed Online. 2019 Mar;38(3):364-379. doi: 10.1016/j.rbmo.2018.12.038. Epub 2019 Jan 2. PMID: 30658892.